Enfusion Names Michael Spellacy as Board Chair and Non-Executive Director
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider…
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider…
KAIZEN to assess safety and efficacy of peripheral orbital atherectomy to secure regulatory approval in…
Five Year Agreement with Brown-Forman Includes Old Forester, Finlandia and Herradura LOUISVILLE, Ky., Jan. 11,…
The 21 award recipients represent an exciting range of stellar achievements across light-based sciences and…
DUBLIN--(BUSINESS WIRE)--The "Global Toxicity Testing Outsourcing Market Size, Share & Industry Trends Analysis Report by…
DUBLIN--(BUSINESS WIRE)--The "Graphene-enhanced Composites Market-Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By…
RUTHERFORD, N.J., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ: BLFY) (the “Company”),…
MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company…
LAS VEGAS--(BUSINESS WIRE)--Lakeside Lightning Semiconductor (LLS), an OLED microdisplay manufacturer based in Jiangsu, China, announced…
– EXKIVITY is the First Category-1 Innovative Drug Approved for Takeda China Following a Phase…